C

Published on 09/02/2015 by admin

Filed under Complementary Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 2.3 (3 votes)

This article have been viewed 1840 times

C

Cancer therapies

Description

Numerous therapies claiming to treat or even to cure cancer have been developed over the years by individuals and organizations, many before the advent of modern chemotherapy. These therapies and interventions are still in demand, largely in response to people’s disenchantment with orthodox medicine, although few have been shown to be effective or safe in clinical trials. It is, however, important for conventional healthcare professionals to appreciate that cancer patients may resort to alternatives, usually as an adjunct, but unfortunately, sometimes as a replacement for orthodox medical treatment and occasionally, as a desperate last resort when conventional medicine can do no more.

Essiac

Bibliography

Eberding A, Madera C, Xie S, et al. Evaluation of the antiproliferative effects of Essiac on in vitro and in vivo models of prostate cancer compared to paclitaxel. Nutrition and Cancer. 2007;58(2):188-196.

Kaegi E. Unconventional therapies for cancer: 1 Essiac. The task force on alternative therapies of the Canadian breast cancer research initiative. Canadian Medical Association Journal. 1998;158(7):897-902.

Kulp KS, Montgomery JL, Nelson DO, et al. Essiac and Flor-Essence herbal tonics stimulate the in vitro growth of human breast cancer cells. Breast Cancer Research and Treatment. 2006;98(3):249-259.

Ottenweller J, Putt K, Blumental E. Inhibition of prostate cancer cell proliferation by Essiac. Journal of Alternative and Complementary Medicine. 2004;10(4):687-691.

Leonard BJ, Kennedy DA, Cheng FC, et al. An in vivo analysis of the herbal compound essiac. Anticancer Research. 2006;26(4B):3057-3063.

Leonard S, Keil D, Mehiman T. Essiac tea: scavenging of reactive oxygen species and effects on DNA damage. Journal of Ethnopharmacology. 2006;103(2):288-296.

Seely D, Kennedy DA, Myers SP, et al. In vitro analysis of the herbal compound Essiac. Anticancer Research. 2007;27(6B):3875-3882.

Tamayo C, Richardson M, Diamond S, et al. The chemistry and biological activity of herbs used in Flor-Essence herbal tonic and Essiac. Phytotherapy Research. 2000;14(1):1-14.

Zick S, Sen A, Feng Y. Trial of Essiac to ascertain its effects in women with breast cancer (TEA-BC). Journal of Alternative and Complementary Medicine. 2006;12(10):971-980.

Gerson diet

Hoxsey herbal treatment

Shark cartilage

Bibliography

Ashar B, Vargo E. Shark cartilage induced hepatitis. Annals of Internal Medicine. 1996;125:780-781.

Bargahi A, Rabbani-Chadegani A. Angiogenic inhibitor protein fractions derived from shark cartilage. Bioscience Reports. 2008;28(1):15-21.

Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941 Shark cartilage) in refractory renal cell carcinoma patients: report of a phase 11 trial with two dose levels. Annals of Oncology. 2002;13(8):1259-1263.

Bukowski R. AE-941 a multifunctional anti-angiogenic compound: trials in renal cell carcinoma. Expert Opinion on Investigational Drugs. 2003;12(8):1403-1411.

Dupont E, Falardeau P, Mousa S, et al. Anti-angiogenic and anti-metastatic properties of Neovastat (AE-941) an orally active extract from cartilage tissue. Clinical and Experimental Metastasis. 2002;19(2):145-153.

Escudier B, Choueiri TK, Oudard S, et al. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract A E 941. Journal of Urology. 2007;178(5):1901-1905.

Hammerness P, Barrette E, Szapary P. Shark cartilage monograph: a clinical decision support tool. Journal of Herbal Pharmacotherapy. 2002;2(2):71-93.

Jiagannath S, Champagne P, Hariton C, et al. Neovastat in multiple myeloma. European Journal of Haematology. 2003;70(4):267-268.

Langman R, Walsh D. Dangerous nutrition? Calcium, vitamin D and shark cartilage nutritional supplements and cancer related hypercalcemia. Supportive Care in Cancer. 2003;11(4):232-235.

Loprinzi C, Levitt R, Barton D, et al. Evaluation of shark cartilage in patients with advanced cancer. Cancer. 2005;104(1):176-182.

Mansberg G. Cancer. Journal of Complementary Medicine. 2006;5(3):18-25.

714-X (Trimethylaminohydroxybicycloheptane chloride)